The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.43BCNY
360.87M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
317.23MCNY
47.11M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-16.46%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.4850x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-30.36%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
2.43BCNY
360.87M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
2.04BCNY
302.39M · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
8.63x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Sales (TTM)
7.68x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Book (MRQ)
4.93x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
6.42x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
-36.37x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Margin
12.48%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 17.28%.Updated Aug 20, 2026
Profit Margin
-16.46%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
-299.14%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
-4.24%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
-13.69%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
317.23MCNY
47.11M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
2.41CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-83.30%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
54.82MCNY
8.14M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
-55.98MCNY
-8.31M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-52.21MCNY
-7.75M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-98.26%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
-55.37MCNY
-8.22M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-20.60MCNY
-3.06M · vs all stocks (USD)
Updated Aug 20, 2026
Payout Ratio
17.48%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Minority Interest (Equity)
5.95MCNYFY2025 · Dec 31, 2025
Revenue
362.53MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
300.66MCNYFY2025 · Dec 31, 2025
Gross Profit
61.87MCNYFY2025 · Dec 31, 2025
Operating Income
-56.42MCNY
-8.38M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-53.41MCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.83MCNYFY2025 · Dec 31, 2025
Net Income
-55.25MCNYFY2025 · Dec 31, 2025
EBIT
-52.71MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-38.28MCNYFY2025 · Dec 31, 2025
Research & Development
27.55MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
45.81MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.30MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.46MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
706.47KCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.3200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.3200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
131.07MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
131.07MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-55.25MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
13.31MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
90.62MCNYFY2025 · Dec 31, 2025
Free Cash Flow
86.98MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
178.26MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-55.25MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.48MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
94.48MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
49.91MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-3.64MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-13.29MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.37BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.42BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
28.67MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.92MCNYFY2025 · Dec 31, 2025
Other Financing Charges
14.95MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
10.03MCNYFY2025 · Dec 31, 2025
Shares Outstanding
130.63MSharesUpdated Aug 20, 2026
Float Shares
85.64MSharesUpdated Aug 20, 2026
% Held by Insiders
41.31%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
4.73%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
430.58MCNY
63.95M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
3.30CNYUpdated Aug 20, 2026
Total Debt (MRQ)
15.90MCNY
2.36M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0340x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.71x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
3.78CNYUpdated Aug 20, 2026
Total Assets
951.18MCNY
141.27M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
753.21MCNYFY2025 · Dec 31, 2025
Total Liabilities
457.47MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
197.97MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
14.24MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
443.23MCNYFY2025 · Dec 31, 2025
Cash
178.26MCNYFY2025 · Dec 31, 2025
Cash Equivalents
76.77MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
255.03MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
202.48MCNYFY2025 · Dec 31, 2025
Accounts Receivable
163.49MCNYFY2025 · Dec 31, 2025
Inventory
63.54MCNYFY2025 · Dec 31, 2025
Accounts Payable
358.26MCNYFY2025 · Dec 31, 2025
Short-term Debt
4.21MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.01KCNYFY2025 · Dec 31, 2025
Long-term Debt
12.36MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
130.63MCNYFY2025 · Dec 31, 2025
Retained Earnings
225.18MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
493.70MCNY
73.32M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
49.83MCNYFY2025 · Dec 31, 2025
52-Week Low
13.80CNYUpdated Aug 20, 2026
52-Week High
31.20CNYUpdated Aug 20, 2026
52-Week Change
-30.36%
vs all stocks
Updated Aug 20, 2026
Beta
0.4850x
vs all stocks
Updated Aug 20, 2026
50-Day MA
16.40CNYUpdated Aug 20, 2026
200-Day MA
20.42CNYUpdated Aug 20, 2026
Avg 10-Day Volume
4.09MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
3.86MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.5300CNYUpdated Aug 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 12.5%, lower than 95% of its Scientific & Technical Instruments peers (median 38.1%)Significant